IIM
NMRA icon

INTECH Investment Management’s Neumora Therapeutics NMRA Stock Holding History

INTECH Investment Management’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.4K Buy
+21,394
New +$40.7K ﹤0.01% 2081
2025
Q2 		– Sell
-73,044
Closed -$73K – 2599
2025
Q1 		$73K Buy
73,044
+39,044
+115% +$66.9K ﹤0.01% 2385
2024
Q4 		$360K Buy
34,000
+20,725
+156% +$248K ﹤0.01% 1737
2024
Q3 		$175K Buy
+13,275
New +$155K ﹤0.01% 1762

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

INTECH Investment Management's NMRA Position: Q2 2026 in Review

INTECH Investment Management opened a new position in Neumora Therapeutics (NMRA) in Q2 2026: 21,394 shares worth $36.4K. The stake represents ﹤0.01% of the portfolio and ranks #2081 among its holdings. This is a return to the name: INTECH Investment Management previously reported a position in NMRA as recently as Q1 2025.

INTECH Investment Management first reported a position in NMRA in Q3 2024 and has held it in 4 quarters since. The position peaked at $360K in Q4 2024. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • INTECH Investment Management held 21,394 shares of Neumora Therapeutics worth $36.4K as of Q2 2026.
  • Neumora Therapeutics was a new INTECH Investment Management position in Q2 2026.
  • Neumora Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #2081 holding.
  • INTECH Investment Management first reported a position in Neumora Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • INTECH Investment Management's Neumora Therapeutics position peaked at $360K in Q4 2024.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.